J. B. Chemicals Board Meeting to Approve Unaudited Financial Results

The Board of Directors of J. B. Chemicals & Pharmaceuticals Limited is scheduled to meet on January 16, 2026. The primary agenda is to consider and approve the unaudited financial results for the quarter and nine months ending on December 31, 2025. This meeting will address the company’s financial performance and strategic direction.

Board Meeting Announcement

J. B. Chemicals & Pharmaceuticals Limited has announced an upcoming meeting of its Board of Directors.

Meeting Details

The board meeting is scheduled for January 16, 2026. The main purpose of the meeting is to review and approve the unaudited financial results. These results will cover the financial performance for Q3 (October-December) and the nine-month period ending December 31, 2025.

Source: BSE

Previous Article

HFCL Limited Promoter Group Reduces Stake via Market Transactions & QIP

Next Article

NHPC Limited Subsidiary RHPCL Shareholding Changes